Th1 Disabled Function in Response to TLR4 Stimulation of Monocyte-Derived DC from Patients Chronically-Infected by Hepatitis C Virus
Author Information
Author(s): Perrin-Cocon Laure, Agaugué Sophie, Diaz Olivier, Vanbervliet Béatrice, Dollet Sandra, Guironnet-Paquet Aurélie, André Patrice, Lotteau Vincent
Primary Institution: Inserm, U851, Lyon, France
Hypothesis
Monocyte-derived dendritic cells (MoDC) from chronically-infected hepatitis C virus (HCV) patients have a defect in Th1 function upon TLR4 stimulation.
Conclusion
Monocytes from HCV patients are activated in vivo, which interferes with their differentiation into dendritic cells, leading to deficient TLR4 signaling and an inability to induce a Th1 response.
Supporting Evidence
- MoDC from HCV patients showed a significantly decreased ability to induce IFNγ secretion by allogeneic T cells compared to healthy individuals.
- The defect in Th1 function was specifically linked to TLR4 stimulation and correlated with lower IL-12 secretion.
- Blocking the MEK/ERK pathway restored the ability of MoDC from HCV patients to stimulate IFNγ secretion.
Takeaway
People with chronic hepatitis C have immune cells that don't work well when they try to respond to certain signals, making it harder for their bodies to fight the virus.
Methodology
Monocyte-derived dendritic cells were stimulated with various TLR ligands, and their ability to induce IFNγ secretion by allogeneic T cells was assessed.
Potential Biases
Potential bias in patient selection and the influence of environmental factors on monocyte function.
Limitations
The study does not explore the long-term effects of HCV on dendritic cell function or the impact of other immune factors.
Participant Demographics
Patients were chronically infected with HCV, with genotypes 1a, 1b, 3, and 4a.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website